Acute lung injury is a life-threatening condition caused by severe acute hypoxemic respiratory failure. It is a key source of mortality and morbidity in critically ill patients without any evidence of hydrostatic pulmonary edema. Market Analysis and Insights: Global Acute Lung Injury Market The global Acute Lung Injury market size is projected to reach US$ 722.9 million by 2027, from US$ 516.7 million in 2020, at a CAGR of 4.9% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Acute Lung Injury market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Acute Lung Injury market in terms of revenue. On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Acute Lung Injury market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Acute Lung Injury market. Global Acute Lung Injury Scope and Market Size Acute Lung Injury market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Acute Lung Injury market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027. Segment by Type Pharmacotherapy Mechanical Ventilation Adjunctive Procedures Fluid Management Others Segment by Application Hospitals Clinics Others By Region North America U.S. Canada Europe Germany France U.K. Italy Russia Nordic Rest of Europe Asia-Pacific China Japan South Korea Southeast Asia India Australia Rest of Asia Latin America Mexico Brazil Rest of Latin America Middle East & Africa Turkey Saudi Arabia UAE Rest of MEA By Company Altor BioScience FirstString Research GlaxoSmithKline Forschung und Entwicklung Commence Bio CompleGen Histocell S.L. Stemedica Cell Technologies Windtree Therapeutics S-Evans Biosciences
1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Acute Lung Injury Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Pharmacotherapy 1.2.3 Mechanical Ventilation 1.2.4 Adjunctive Procedures 1.2.5 Fluid Management 1.2.6 Others 1.3 Market by Application 1.3.1 Global Acute Lung Injury Market Share
